Objective Type 2 diabetes mellitus (T2DM) is often accompanied by undiagnosed
dyslipidemia. Research on the association of unconventional lipid markers with prediabetes …

Background and aims The current systematic review aimed to elucidate the effects of lipid
variability on microvascular complication risk in diabetic patients. The lipid components …

National Heart Center/Saudi Heart Association 2023 Guidelines on the Management of
Hypertension - PMC Back to Top Skip to main content NIH NLM Logo Access keys NCBI …

Diabetes Mellitus (DM) causes global exhaustion, consumes economic resources, and has
several risk factors. The bibliometric studies re-evaluate the research efforts on this illness …

Oxidative stress plays a leading role in the pathogenesis of diabetic nephropathy. However,
many aspects of oxidative stress reactions in the initial stages of this disease are not fully …

Purpose ANGPTL8, commonly referred to as betatrophin, has demonstrated promise as a
dependable marker for the onset of complications associated with diabetes mellitus, such as …

AIM: To evaluate and compare the safety and efficacy of rosuvastatin, simvastatin, and
atorvastatin in patients of type 2 diabetes mellitus with dyslipidemia. MATERIALS AND …

Dyslipidemia in obese adolescents is a marker of early-onset cardiovascular problems such
as atherosclerosis. The purpose of this study was to identify the magnitude of the problem of …

Dyslipidemia is a major cause of cardiovascular complications in diabetes mellitus. This
study was carried out to evaluate the modulatory effect of Terminalia catappa leaf extract on …

Background: Children and adolescents with insulin-dependent diabetes mellitus (IDDM) are
at high risk of metabolic disorders that may interfere with lipid metabolism and predispose to …